However, although these different types of novel PAI-1inhibitors have been shown to be efficient in vivo or in vitro, their role and safety in cancers remain unclear and require more research and clinical trials to understand them, but they still promise a bright future for cancer therapies based on SERPINE1. The gene discussed is SERPINE1; the disease is cancer.